Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 8 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 3 analysts offering 12 month price targets for Lushang Freda Pharmaceutical Co Ltd have a median target of 9.50, with a high estimate of 13.00 and a low estimate of 8.21. The median estimate represents a 53.47% increase from the last price of 6.19.
High | 110.0% | 13.00 |
Med | 53.5% | 9.50 |
Low | 32.6% | 8.21 |
Dividends
Div growth (TTM) | -- |
---|
More ▼
Earnings history & estimates in CNY
Average growth rate | +247.43% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +2.25% |
More ▼